Items related to Role of Roflumilast Among COPD Patients to Prevent...

Role of Roflumilast Among COPD Patients to Prevent Exacerbations: Oral Roflumilast as a New Treatment Modality for COPD Exacerbations - Softcover

Laique, Talha; Latif, Hina; Farooq Butt, Nasir

 
9786209935633: Role of Roflumilast Among COPD Patients to Prevent Exacerbations: Oral Roflumilast as a New Treatment Modality for COPD Exacerbations
Softcover
ISBN 10: 620993563X ISBN 13: 9786209935633
Publisher: LAP LAMBERT Academic Publishing, 2026

Synopsis

Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory disorder and a major cause of morbidity and mortality worldwide, particularly in low- and middle-income countries such as Pakistan, where underdiagnosis and limited healthcare resources remain significant challenges. Despite standard therapies, frequent exacerbations continue to worsen patient outcomes and increase healthcare burden.Roflumilast, an oral phosphodiesterase-4 (PDE-4) inhibitor, has emerged as a promising new treatment option for severe COPD with recurrent exacerbations. This study evaluates the effectiveness and safety of oral roflumilast as an adjunct to standard therapy in preventing exacerbations and improving pulmonary function among COPD patients.

"synopsis" may belong to another edition of this title.

Publisher
LAP LAMBERT Academic Publishing
Publication date
2026
Language
English
ISBN 10 
620993563X
ISBN 13 
9786209935633
Binding
Paperback
Number of pages
88